| 1 |
Warfarin sodium
| 1件: Warfarin Warfarin | 2件: Warfarin Warfarin; Warfarin Sodium; | 2件: NQO1 NQO1,
VKORC1 💬 | 7件: Biosynthesis of cofactors Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | 13件: 6 6, 8, 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 |
| 2 |
Warfarin potassium
| 1件: Warfarin Warfarin | 2件: Warfarin Warfarin; Warfarin Sodium; | 2件: NQO1 NQO1,
VKORC1 💬 | 7件: Biosynthesis of cofactors Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | 13件: 6 6, 8, 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 |
| 3 |
Rivaroxaban
| 1件: Rivaroxaban Rivaroxaban | 2件: RIVAROXABAN RIVAROXABAN; Xarelto; | 1件: F10 F10 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 5件: 46 46, 49, 75, 91, 210 |
| 4 |
Warfarin
| 1件: Warfarin Warfarin | 2件: Warfarin Warfarin; Warfarin Sodium; | 2件: NQO1 NQO1,
VKORC1 💬 | 7件: Biosynthesis of cofactors Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | 13件: 6 6, 8, 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 |
| 5 |
Dabigatran
| 1件: Dabigatran Dabigatran | 1件: Dabigatran Dabigatran; | 1件: F2 F2 💬 | 8件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬 | 4件: 51 51, 85, 91, 124 |